BETA DRUGS LIMITED Share Price

₹ 1,790.00

-₹8.40 (-0.47%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: BETA
|
Pharmaceuticals

BETA DRUGS LIMITED Share Price Today

As of 2 Nov 2026, BETA DRUGS LIMITED share price is ₹1,790.00. The stock opened at ₹1,781.00, compared to its previous close of ₹1,798.40. During today's trading session, BETA DRUGS LIMITED share price moved in the range of ₹1,750.20 to ₹1,790.00, with an average price of ₹1,770.10 for the day. Looking at its last 52-week, the stock has touched a low of ₹990.10 and a high of ₹2,807.90. On the performance front, BETA DRUGS LIMITED share price has increased by 35.21% over the last six months and is down 3.17% on a year-on-year basis.

Share price over the last 1 day rose from 1756.80 to 1790.00, ranging between 1753.20 and 1790.00.
₹1,750.20
0.47% down today
₹1,790.00
1D LOW
1D HIGH

BETA DRUGS LIMITED Stock Insights

Latest Earning
Op Profit TrendUp by 16.97% QoQ
Latest Earning
Net Profit TrendUp by 16.92% QoQ
Latest Earning
Revenue TrendUp by 9.53% QoQ
Stock Performance
OutperformingBeat Nifty by 41.11 % in last 6 month
Shareholding Pattern
PromoterPromoter decreased stake by 0.32%
Shareholding Pattern
DIIDII increased stake by 3.46%
Shareholding Pattern
FIIFII increased stake by 34.53%
BETA DRUGS LIMITED stock performance
Open₹1,781.00
High₹1,790.00
Low₹1,750.20
Prev. close₹1,798.40
BETA DRUGS LIMITED trading activity
Volume12,136
Average traded price₹1,771.43
Last traded time03:29:21 02 Nov
Last traded quantity3
Circuit
L
H
₹1,438.80
₹2,158.00
52-week
L
H
₹990.10
₹2,807.90
Mkt Cap Cr
2,000.05
P/E
37.5
P/B
4.57
ROA
8.13%
ROE
11.86%
ROCE
16.78%
Quick Ratio
2.41
EV/EBITDA
19.29

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Beta Drugs Ltd has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Beta Drugs Ltd appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
Beta Drugs Ltd revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

BETA DRUGS LIMITED Company Background

ISIN
INE351Y01019
Sector Market Cap
₹ 2,000.05 Cr

Beta Drugs Limited is an India-based oncology medicine manufacturing company. The Company specializes in the intricate field of complex chemical synthesis for anti-cancer bulk drugs and finished dosages. The Company operates through one segment, Pharmaceuticals. Its product category includes cosmeceutical products and oncology products. The cosmeceutical products include La’Thrix, BACINOX, URTICALM, HUMIDA, NUSPLASH, UVIREX, ADVIBE, SENSIBAR, and RECAPRO. The oncology products include Temozad(Temozolomide), ADVIN(Vinorelbine), ADSIDE(Etoposide), ADRIB(Doxorubicin), ADCOV(Leucovorin calcium), ADPLATIN(Oxaliplatin), INOTAD(Irinotecan), ADCIST(Cisplatin), ADCARB(Carboplatin), ERLOTAD(Erlotinib), ADOXI(Docetaxel), AMGICIN(Gemcitabine), ADPAXIL(Paclitaxel), ADMIDE(Bicalutamide), and others. The Company's subsidiaries include Adley Lab Limited and Adley Formulations Private Limited.

BETA DRUGS LIMITED Financial Highlights

  • Revenue: BETA DRUGS LIMITED reported revenue of ₹396.01 crore in FY26 vs ₹368.80 crore in FY25. It showed an increase of 7.38% on a yearly basis.
  • Operating Profit: BETA DRUGS LIMITED reported an operating profit of ₹54.39 crore in FY26 vs ₹56.97 crore in FY25. It showed a decrease of 4.53% on a year-on-year basis.
  • Net Profit: BETA DRUGS LIMITED reported a net profit of ₹41.48 crore in FY26 vs ₹42.42 crore in FY25. It showed a decrease of 2.22% on a yearly basis.

BETA DRUGS LIMITED Quarterly Result Highlights

  • BETA DRUGS LIMITED reported revenue of ₹139.24 crore in Sep 2026, compared with ₹127.13 crore in Jun 2026, representing an increase of 9.53% on a quarter-on-quarter (QoQ) basis.
  • BETA DRUGS LIMITED reported an operating profit of ₹25.78 crore in Sep 2026, compared with ₹22.04 crore in Jun 2026, representing an increase of 16.97% on a quarter-on-quarter (QoQ) basis.
  • BETA DRUGS LIMITED reported a profit of ₹19.28 crore in Sep 2026, compared with ₹16.49 crore in Jun 2026, reflecting an increase of 16.92% on a QoQ basis.
  • The earnings per share (EPS) of BETA DRUGS LIMITED stood at ₹40.92 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
58.91%
FII
1.37%
Other DII
6.45%
Retail and other
33.27%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20260.90%
May 20262.95%
Jun 20261.02%
Sep 20261.37%

BETA DRUGS LIMITED Investment Returns

1 day
-2.77%
1 week
-5.08%
1 month
-12.40%
1 year
-3.17%
3 years
+94.42%
5 years
+243.33%

BETA DRUGS LIMITED Share Price History

BETA DRUGS LIMITED share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹1,880.60 / ₹1,798.40
-2.77%
29 Oct 26
₹1,976.80 / ₹1,849.70
-6.43%
28 Oct 26
₹1,955.00 / ₹1,976.80
+2.20%
27 Oct 26
₹1,977.90 / ₹1,934.20
-2.21%
Show more

BETA DRUGS LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹384.83₹362.36₹295.71₹227.11
Other Income₹11.18₹6.44₹1.36₹0.75
Total Revenue₹396.01₹368.79₹297.07₹227.87
Total Expenses₹341.61₹307.25₹248.32₹186.81
Profit Before Tax₹54.39₹56.97₹48.75₹41.06
Tax₹12.91₹14.55₹12.32₹10.34
Profit After Tax₹41.48₹42.42₹36.44₹30.72
EPS - Basic₹40.92₹42.02₹37.90₹31.95
EPS - Diluted₹40.92₹42.02₹37.90₹31.95

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹54.39₹61.54₹48.75₹41.06
Income before WC changes₹64.27₹55.17₹44.51₹43.08
Change in Assets-₹36.95-₹34.82-₹40.71-₹28.89
Change in Liabilities₹9.96₹15.79₹27.14₹9.19
Change in WC-₹26.99-₹19.03-₹13.58-₹19.69
Cash flow from Operations₹37.29₹36.14₹30.93₹23.38
Cash flow from Investing-₹51.39-₹35.72-₹13.97-₹19.07
Cash flow from Financing-₹8.07₹117.97-₹7.49-₹2.47
Total Cash Flow-₹22.18₹118.39₹9.47₹1.84
Cash (Start of the year)₹147.02₹28.63₹19.16₹17.32
Cash (End of the year)₹124.85₹147.02₹28.63₹19.16

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹160.64₹105.16₹76.23₹70.74
Current Assets₹335.16₹331.08₹177.87₹127.68
Total Assets₹495.80₹436.23₹254.10₹198.42
Current Liabilities₹108.14₹102.73₹84.67₹63.02
Net Current Asset₹227.02₹228.35₹93.20₹64.67
Non-Current Liabilities₹142.89₹136.41₹12.31₹12.52
Equity Capital₹244.77₹197.10₹157.12₹122.88
Total Equity & Liabilities₹495.80₹436.23₹254.10₹198.42

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹225.43₹220.20₹197.62₹157.87
Other Income₹11.14₹6.19₹1.73₹1.04
Total Revenue₹236.57₹226.39₹199.35₹158.92
Total Expenses₹218.36₹200.98₹169.87₹133.71
Profit Before Tax₹18.21₹20.84₹29.48₹25.21
Tax₹3.88₹5.41₹7.55₹6.39
Profit After Tax₹14.33₹15.43₹21.94₹18.82
EPS - Basic₹14.14₹15.29₹22.82₹19.57
EPS - Diluted₹14.14₹15.29₹22.82₹19.57

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹18.21₹25.41₹29.48₹25.21
Income before WC changes₹25.94₹17.86₹23.19₹25.63
Change in Assets-₹10.55-₹11.85-₹19.27-₹20.03
Change in Liabilities₹3.82₹12.03₹17.26₹4.62
Change in WC-₹6.74₹0.18-₹2.01-₹15.41
Cash flow from Operations₹19.20₹18.04₹21.19₹10.23
Cash flow from Investing-₹31.31-₹21.46-₹11.02-₹5.82
Cash flow from Financing-₹11.44₹118.20-₹0.76-₹2.19
Total Cash Flow-₹23.55₹114.79₹9.40₹2.21
Cash (Start of the year)₹141.99₹27.20₹17.79₹15.58
Cash (End of the year)₹118.44₹141.99₹27.20₹17.79

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹116.73₹85.30₹56.80₹49.04
Current Assets₹218.22₹231.22₹113.67₹85.00
Total Assets₹334.96₹316.52₹170.47₹134.04
Current Liabilities₹54.24₹57.53₹47.66₹31.47
Net Current Asset₹163.98₹173.69₹66.01₹53.53
Non-Current Liabilities₹131.16₹129.96₹6.80₹6.32
Equity Capital₹149.56₹129.04₹116.01₹96.26
Total Equity & Liabilities₹334.96₹316.52₹170.47₹134.04
* All values are in INR Crore
BETA DRUGS LIMITED market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
BETA DRUGS LIMITED technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
43.01
Neutral
ATR (14)
158.21
Neutral
STOCH(9,6)
37.72
Neutral
STOCH RSI (14)
66.34
Neutral
ADX(9)
21.46
Bearish
UO(9)
49.16
Neutral
ROC(12)
7.19
Bullish
WillR(14)
-62.28
Neutral
Period
Simple value
Exponential vaue
5D
1907.4
1866.66
10D
1856.99
1870.41
20D
1873
1898.94
50D
2048.54
1994.53
100D
2122.25
1962.24
Volume trend — traded volume by day
2 Nov0L
30 Oct0L
29 Oct0L
28 Oct0L
27 Oct0L
26 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

BETA DRUGS LIMITED
Pharmaceuticals
Add Stock
Add Another

BETA DRUGS LIMITED Returns Calculator

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

BETA DRUGS LIMITED Share Price FAQs

Please be aware that BETA DRUGS LIMITED stock prices are subject to continuous fluctuations due to various factors.